MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$7,877K
Net Income
-$153,067K
Net Profit Margin
-1943.21%
EPS
-$24.14
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
7,877
5,686
21,942
2,149
General and administrative
46,565
4,152
3,453
4,939
Research and development
49,007
6,897
16,532
4,754
Gain (loss) on fixed asset disposal
-
-
20
-51
Gain on lease termination
0
10
-
-
Total operating expenses
95,572
11,039
19,965
9,744
Gain from operations
-87,695
-5,353
1,977
-7,595
Interest income
157
179
217
222
Interest expense
-5
-4
-109
-75
Loss on issuance of liability-classified warrants and related issuance costs
-90,011
-
-
-
Changes in fair value of financial instruments
24,487
-
-
-
Total other income (expense), net
-65,372
175
108
147
Loss before provision for income taxes
-
-
-1,710*
-
Provision for income taxes
-
-
125*
-
Net gain
-153,067
-5,178
1,585
-7,448
Unrealized gain from available-for-sale securities
-
-
-
1
Comprehensive loss
-
-
-
-7,447
Basic EPS
-24.14
-1.08
0.015
-0.07
Diluted EPS
-24.14
-1.08
0.015
-0.07
Basic Average Shares
6,340,844
4,807,494
108,343,622
100,869,349
Diluted Average Shares
6,340,844
4,807,494
108,343,622
100,869,349
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net gain-$153,067K (-1704.61%↓ Y/Y)Gain from operations-$87,695K (-915.58%↓ Y/Y)Total other income(expense), net-$65,372K (-42826.80%↓ Y/Y)Collaboration revenue$7,877K (166.66%↑ Y/Y)Changes in fair value offinancial instruments$24,487K Interest income$157K (-20.71%↓ Y/Y)Total operatingexpenses$95,572K (724.68%↑ Y/Y)Loss on issuance ofliability-classified warrants and...-$90,011K Interest expense-$5K (88.89%↑ Y/Y)Research and development$49,007K (519.56%↑ Y/Y)General andadministrative$46,565K (1165.70%↑ Y/Y)

Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. (CUE)